Jan Wahlström steps down as CEO of Elos Medtech
Chief Executive Officer and President Jan Wahlström has decided to vacate his position at Elos Medtech AB. He will remain in his current position during his period of notice or until another alternative solution is in place. The process of finding a successor for Jan starts immediately.
“We would like to thank Jan for his achievements as CEO and President of Elos Medtech,” says Lovisa Lander, Chairman of the Elos Medtech Board. “Under Jan’s leadership, the company has undergone a successful growth journey, further developing into a strong platform that is focused on supporting the Group’s customers on a global basis. On behalf of the Board of Directors, I want to thank Jan greatly and wish him all the best in the future,” says Lovisa Lander, Chairman of the Board.
“I have had the privilege of working with fantastic employees and I am proud of what we have accomplished together,” says Jan Wahlström, CEO and President. “During the more than five years in my role as CEO, we have transformed the business strategically while increasing both profitability and growth. We have strengthened our customer relationships based on both investments and dedicated work with a strong focus on customer’s needs. The Group is facing an exciting journey and I look forward to following Elos Medtech's development. I wish the company and its employees all the best the years to come,” says Jan Wahlström, CEO and President.
About Elos Medtech
Elos Medtech is a leading development and production partner for medical devices and components, with a focus on dental and orthopedic implants and instruments. The company operates from facilities in Sweden, Denmark, China, and the U.S. The customer base comprises international medical technology companies.
Elos Medtech has more than 500 employees and a turnover of more than SEK 550 million. Elos Medtech has been listed on NASDAQ Stockholm AB since 1989. Elos Medtech’s B share is categorized as a Health Care company on the Mid Cap list.
Göteborg, January 12, 2022
Elos Medtech AB (publ)
For further information, please contact:
Lovisa Lander, Chairman of the Board, +44 (0)20 7823 0211, e-post: firstname.lastname@example.org
For additional information about the Elos Medtech Group, visit www.elosmedtech.com
This is information that Elos Medtech AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above on January 12, 2022, at 11:15 a.m. (CET)